Zum Hauptinhalt springen
Dekorationsartikel gehören nicht zum Leistungsumfang.
Drugs and the FDA
Safety, Efficacy, and the Public's Trust
Buch von Mikkael A Sekeres
Sprache: Englisch

30,50 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Aktuell nicht verfügbar

Kategorien:
Beschreibung
"The tension between the drugs patients need & what is necessary to demonstrate safety & efficacy; a story of hope in justifiably desperate patients vs. the time it takes to prove drugs actually work"--]cProvided by publisher.
"The tension between the drugs patients need & what is necessary to demonstrate safety & efficacy; a story of hope in justifiably desperate patients vs. the time it takes to prove drugs actually work"--]cProvided by publisher.
Über den Autor
Mikkael A. Sekeres is Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, and former Chair of the Oncologic Drugs Advisory Committee of the FDA. A regular contributor to the Well section of the New York Times, he is the author of When Blood Breaks Down: Life Lessons from Leukemia (MIT Press).
Inhaltsverzeichnis
Preface ix
1 This Little Drug Came to Market... 1
2 And Finally, Efficacy 29
3 The Moxie to Do Battle 53
4 Trials and Tribulations 77
5 Starve a Tumor, Feed an Industry 107
6 A Viral Scourge 131
7 Silence = Death 155
8 The FDA Makes Its Case 185
9 The Avastin Decision 215
Epilogue 247
Acknowledgments 259
Appendix 261
Notes 267
Index 299
Details
Erscheinungsjahr: 2022
Fachbereich: Handels- und Wirtschaftsrecht, Arbeitsrecht
Genre: Recht
Produktart: Nachschlagewerke
Rubrik: Recht & Wirtschaft
Medium: Buch
ISBN-13: 9780262047319
ISBN-10: 0262047314
Sprache: Englisch
Einband: Gebunden
Autor: Sekeres, Mikkael A
Hersteller: Penguin Random House LLC
Maße: 230 x 156 x 31 mm
Von/Mit: Mikkael A Sekeres
Erscheinungsdatum: 27.09.2022
Gewicht: 0,574 kg
Artikel-ID: 121340377
Über den Autor
Mikkael A. Sekeres is Professor of Medicine and Chief of the Division of Hematology at the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, and former Chair of the Oncologic Drugs Advisory Committee of the FDA. A regular contributor to the Well section of the New York Times, he is the author of When Blood Breaks Down: Life Lessons from Leukemia (MIT Press).
Inhaltsverzeichnis
Preface ix
1 This Little Drug Came to Market... 1
2 And Finally, Efficacy 29
3 The Moxie to Do Battle 53
4 Trials and Tribulations 77
5 Starve a Tumor, Feed an Industry 107
6 A Viral Scourge 131
7 Silence = Death 155
8 The FDA Makes Its Case 185
9 The Avastin Decision 215
Epilogue 247
Acknowledgments 259
Appendix 261
Notes 267
Index 299
Details
Erscheinungsjahr: 2022
Fachbereich: Handels- und Wirtschaftsrecht, Arbeitsrecht
Genre: Recht
Produktart: Nachschlagewerke
Rubrik: Recht & Wirtschaft
Medium: Buch
ISBN-13: 9780262047319
ISBN-10: 0262047314
Sprache: Englisch
Einband: Gebunden
Autor: Sekeres, Mikkael A
Hersteller: Penguin Random House LLC
Maße: 230 x 156 x 31 mm
Von/Mit: Mikkael A Sekeres
Erscheinungsdatum: 27.09.2022
Gewicht: 0,574 kg
Artikel-ID: 121340377
Warnhinweis